Cargando…

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

RATIONALE: It is difficult to predict the effects of long-acting bronchodilators (LABD) on lung function, exercise capacity and physical activity in patients with chronic obstructive pulmonary disease (COPD). Therefore, the multidimensional response to LABD was profiled in COPD patients participatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koopman, Maud, Franssen, Frits M E, Gaffron, Swetlana, Watz, Henrik, Troosters, Thierry, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Moya, Miguel, van Burk, Lindy, Maier, Dieter, Garcia Gil, Esther, Wouters, Emiel F M, Vanfleteren, Lowie E G W, Spruit, Martijn A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943652/ https://www.ncbi.nlm.nih.gov/pubmed/35342289 http://dx.doi.org/10.2147/COPD.S308600

Ejemplares similares

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
por: Watz, Henrik, et al.
Publicado: (2017)

Biomarker-based clustering of patients with chronic obstructive pulmonary disease
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2023)

Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study
por: Posthuma, Rein, et al.
Publicado: (2023)

The respiratory physiome: Clustering based on a comprehensive lung function assessment in patients with COPD
por: Augustin, Ingrid M. L., et al.
Publicado: (2018)

Effects of Non-Invasive Ventilation Combined with Oxygen Supplementation on Exercise Performance in COPD Patients with Static Lung Hyperinflation and Exercise-Induced Oxygen Desaturation: A Single Blind, Randomized Cross-Over Trial
por: Koopman, Maud, et al.
Publicado: (2019)

Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging
por: Triest, Filip J. J., et al.
Publicado: (2019)

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
por: Sethi, Sanjay, et al.
Publicado: (2019)

New combinations in the treatment of COPD: rationale for aclidinium–formoterol
por: Incorvaia, Cristoforo, et al.
Publicado: (2016)

Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
por: Franssen, Frits M.E., et al.
Publicado: (2019)

Clustering based on comorbidities in patients with chronic heart failure: an illustration of clinical diversity
por: Uszko‐Lencer, Nicole H.M.K., et al.
Publicado: (2021)

Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
por: Singh, Dave, et al.
Publicado: (2017)

Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
por: Rivero-Ferrer, Elena, et al.
Publicado: (2022)

Comprehensive Lung Function Assessment Does not Allow to Infer Response to Pulmonary Rehabilitation in Patients with COPD
por: Augustin, Ingrid M. L., et al.
Publicado: (2018)

Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores
por: Houben-Wilke, Sarah, et al.
Publicado: (2018)

The superexacerbator phenotype in patients with COPD: a descriptive analysis
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2019)

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
por: D’Urzo, Anthony D, et al.
Publicado: (2019)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
por: Moitra, Subhabrata, et al.
Publicado: (2015)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
por: Matera, Maria Gabriella, et al.
Publicado: (2016)

An Evaluation of the Pharmacokinetics, Safety, and Tolerability of Aclidinium/Formoterol Fixed-Dose Combination Administered in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
por: Zhang, Hong, et al.
Publicado: (2022)

Increased exercise tolerance using daytime mouthpiece ventilation for patients with diaphragm paralysis
por: Koopman, Maud, et al.
Publicado: (2017)

Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD
por: Andrianopoulos, Vasileios, et al.
Publicado: (2014)

Domain-specific cognitive impairment in patients with COPD and control subjects
por: Cleutjens, Fiona AHM, et al.
Publicado: (2016)

Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison
por: Medic, Goran, et al.
Publicado: (2016)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
por: Miravitlles, Marc, et al.
Publicado: (2016)

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
por: Singh, Dave, et al.
Publicado: (2014)

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
por: Bateman, Eric D., et al.
Publicado: (2015)

Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD
por: D’Urzo, Anthony, et al.
Publicado: (2017)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
por: D’Urzo, Anthony D., et al.
Publicado: (2019)

Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
por: Franssen, Frits ME, et al.
Publicado: (2011)

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD
por: Ramos, Mafalda, et al.
Publicado: (2016)

Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018)

The COgnitive-Pulmonary Disease (COgnitive-PD) study: protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPD
por: Cleutjens, Fiona A H M, et al.
Publicado: (2014)

Prevalence of Metabolic Syndrome in COPD Patients and Its Consequences
por: Breyer, Marie-Kathrin, et al.
Publicado: (2014)

New Pharmacologic Perspectives in Pneumology: Beclomethasone-Formoterol Extrafine
por: Paggiaro, Pierluigi
Publicado: (2009)

Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease
por: Cleutjens, Fiona A H M, et al.
Publicado: (2017)

Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients
por: Augustin, Ingrid M. L., et al.
Publicado: (2022)

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
por: D’Urzo, Anthony D, et al.
Publicado: (2014)

Airflow Obstruction and Cardio-metabolic Comorbidities
por: Triest, Filip J.J., et al.
Publicado: (2019)

Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study
por: Wilke, Sarah, et al.
Publicado: (2012)

Metabolic and Structural Changes in Lower-Limb Skeletal Muscle Following Neuromuscular Electrical Stimulation: A Systematic Review
por: Sillen, Maurice J. H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tbim378tc5tt95tiag7h5v3njb